| scholarly article | Q13442814 |
| P2093 | author name string | Opdenakker G | |
| de Wolf-Peeters C | |||
| van den Oord JJ | |||
| Paemen L | |||
| P2860 | cites work | The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily | Q28304981 |
| A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma | Q34710725 | ||
| Tumor invasion and metastasis: an imbalance of positive and negative regulation. | Q37289935 | ||
| Type IV collagenases in tumor invasion and metastasis | Q37573601 | ||
| Gelatinase A activity directly modulates melanoma cell adhesion and spreading. | Q37694676 | ||
| Parenchymal-Stromal Interactions in Neoplasia: Theoretical considerations and observations in melanocytic neoplasia | Q40423335 | ||
| The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells | Q41295099 | ||
| Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. | Q41435602 | ||
| Tumor Cell Invasion Inhibited by TIMP-2 | Q41679983 | ||
| Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells | Q41729440 | ||
| Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. | Q42009063 | ||
| Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization | Q42450642 | ||
| Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues | Q43981537 | ||
| Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells | Q44587910 | ||
| A classification of melanocytic dysplasias and malignant melanomas. | Q53555374 | ||
| Monoclonal Antibodies Specific for Natural Human Neutrophil Gelatinase B Used for Affinity Purification, Quantitation by Two-Site ELISA and Inhibition of Enzymatic Activity | Q57584759 | ||
| Differential regulation of gelatinase b and tissue-type plasminogen activator expression in human bowes melanoma cells | Q57584781 | ||
| Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines | Q67849291 | ||
| Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value | Q71870892 | ||
| Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase | Q72800589 | ||
| Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody | Q73582843 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular matrix | Q193825 |
| P304 | page(s) | 665-670 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin | |
| P478 | volume | 151 |
| Q42026021 | Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin |
| Q35234354 | Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma |
| Q36038630 | CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas |
| Q36398938 | CD147 immunoglobulin superfamily receptor function and role in pathology |
| Q34896891 | CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes |
| Q55255614 | Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice. |
| Q44410097 | EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma |
| Q33687242 | EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2. |
| Q78848849 | EMMPRIN-mediated MMP regulation in tumor and endothelial cells |
| Q35107639 | Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function |
| Q36617718 | Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas |
| Q37561552 | Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation |
| Q37496744 | Links between CD147 function, glycosylation, and caveolin-1. |
| Q33277424 | Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma |
| Q33652022 | Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer |
| Q38273599 | Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression |
| Q36621338 | Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression |
| Q38673407 | Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy. |
| Q37777976 | Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target. |
| Q40857787 | Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. |
| Q36178379 | Role of nuclear factor-kappa B in melanoma |
| Q36916433 | TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin. |
| Q43879024 | The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies |
| Q41124607 | The effect of imiquimod on matrix metalloproteinases and tissue inhibitors of metalloproteinases in malignant melanoma cell invasion. |
| Q36957830 | The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region. |
| Q39205891 | The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines |
| Q21131317 | The regulation of MMP targeting to invadopodia during cancer metastasis |
| Q35842240 | Tumorigenic potential of extracellular matrix metalloproteinase inducer |
Search more.